Imatinib: Transforming Cancer Treatment with Targe..

skapat en ny artikel

13 i

Imatinib: Transforming Cancer Treatment with Targeted Therapy | #imatinib Supplier

Imatinib: Transforming Cancer Treatment with Targeted Therapy

Imatinib: Transforming Cancer Treatment with Targeted Therapy

Imatinib is a tyrosine kinase inhibitor (TKI) that specifically targets the BCR-ABL fusion protein, an abnormal enzyme produced by a genetic mutation responsible for chronic myeloid leukemia (CML) and some forms of acute lymphoblastic leukemia (ALL).

Tycka om

Kommentar

Dela med sig